Skip to content

Elderly Patients and COVID-19 Infection: a Cohort of Fifty Patients Over Ninety Years of Age

Elderly Patients and COVID-19 Infection: a Cohort of Fifty Patients Over Ninety Years of Age

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04499300
Enrollment
50
Registered
2020-08-05
Start date
2020-06-09
Completion date
2020-11-23
Last updated
2022-03-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Covid19

Brief summary

SARS-CoV2 or CoVid19 disease is a newly described pathology linked to a subtype of the coronavirus family identified in China in December 2019. This pathology can present multiple clinical facets, ranging from asymptomatic forms to more commonly critical pulmonary forms called Acute Respiratory Distress Syndrome. The elderly population is more at risk for this infection due to the senescence of the immune system, co-morbidities and poly medications. They also often present a greater state of fragility. This study aims to report the epidemiology of the first 50 patients over 90 years of age hospitalized within the CHU Brugmann hospital.

Interventions

Data collection from medical files

Sponsors

Murielle Surquin
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
90 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Be over 90 years of age on the date of admission to CHU Brugmann Hospital * Have a SARS Cov2 infection proven by antigen or RT-PCR on smear and / or typical imaging regardless of the clinical manifestation * Have been hospitalized at CHU Brugmann between 03/01/2020 and 05/10/2020

Exclusion criteria

None

Design outcomes

Primary

MeasureTime frameDescription
Hypoxemia5 minutesVital signs at hospital admission: Hypoxemia
Tachycardia5 minutesVital signs at hospital admission:Tachycardia
Signs and symptoms5 minutesPresence and date of first apparition: Fever, Cough, Dyspnea, Chest pain, Nausea or vomiting, Diarrhea, Fatigue, Anosmia, ageusia, inappetence, Confusion, Fall, Fracture
Demographic data5 minutesAge, sex, ethnicity
Comorbidities5 minutesSmoking, Obesity, Diabetes, Arterial hypertension, Coronary pathology, Cerebrovascular disease, chronic renal failure, chronic obstructive pulmonary disease, Neoplasia, Autoimmune disease, Chronic liver disease
Cumulative Illness Rating Scale-Geriatric (CIRS-G)5 minutesCIRS-G quantifies burden of disease in elderly patients (comorbidity scale). Higher scores indicate higher severity (maximum score = 56 points).
Treatments5 minutesUnder Chronic corticosteroid therapy or Immunosuppressive therapy
Fever5 minutesVital signs at hospital admission: Fever
Hypotension5 minutesVital signs at hospital admission: Hypotension
Gasometry5 minutesVital signs at hospital admission: Gasometry
Infectious data5 minutesContact with confirmed covid person before admission, lives in a retirement home with other cases, Initial bacterial or viral co-infection, Bacterial or viral co-infection during the hospital stay
Blood count5 minutesBlood count at hospital admission or first recorded
Ionogram5 minutesIonogram at hospital admission or first recorded
Liver function5 minutesLiver function at hospital admission or first recorded
Coagulation5 minutesCoagulation at hospital admission or first recorded
Renal function5 minutesRenal function at hospital admission or first recorded
Albumin5 minutesAlbumin at hospital admission or first recorded
CRP5 minutesCRP at hospital admission or first recorded
Fibrinogen5 minutesFibrinogen at hospital admission or first recorded
D-dimers at hospital admission or first recorded5 minutesD-dimers
NTproBNP5 minutesNTproBNP at hospital admission or first recorded
CK5 minutesCK at hospital admission or first recorded
Troponin5 minutesTroponin at hospital admission or first recorded
Ferritin5 minutesFerritin at hospital admission or first recorded
Procalcitonin5 minutesProcalcitonin at hospital admission or first recorded
Biology - highest rate5 minutesHighest rate of CRP, D-Dimers, Urea, Creatinin, Fibrinogen, CK, Troponins
Biology - lowest rate5 minutesLowest rate of hemoglobin, platelets, leucocytes, lymphocytes, albumin, Na+, K+
Percentage of pulmonary involvement on chest CT scan5 minutesPercentage of pulmonary involvement on chest CT scan
Number of pulmonary lobes affected5 minutesNumber of pulmonary lobes affected
Type of lesions5 minutesType of lesions as reflected on the CT scan images: 'Ground glass' or 'Crazy paving'
Need for oxygenotherapy5 minutesNeed for oxygenotherapy (yes/no)
Means of ventilation5 minutesMeans of ventilation
Treatment received5 minutesHydroxychloroquine or Azithromycin
Length of ICU Stay5 minutesLength of ICU Stay
Status at hospital exit5 minutesOne of the following choices: death, went back home, went back to a retirement home, was placed in a revalidation unit.
Mortality5 minutes28-day mortality after PCR / CT scan / diagnosis

Countries

Belgium

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026